Ryohkan Funakoshi
6PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 07, 2025
Effectiveness of Outpatient Pharmaceutical Clinics in the Overseeing of Self-Injectable Biologic Prescriptions for Inflammatory Immune Diseases and the Cost-Effectiveness of Pharmacological Management.Hiroki Oba, Ikkou Hirata, Masaki Inoue
|Sep 27, 2025
Changes in the trend and quality of adverse drug reaction reports in the Japanese Adverse Drug Event Report database and the impact of COVID-19-related reports.Masami Tsuchiya, Takamasa Sakai, Naoto Okada
|Sep 20, 2025
Comparative analysis of the characteristics and trends of adverse drug reaction reports from patients in Japan and the Japanese Adverse Drug Event Report database.Masami Tsuchiya, Ryohkan Funakoshi, Koichi Masuyama
|Jul 15, 2024
External Validation and Update of the Risk Prediction Model for Denosumab-Induced Hypocalcemia Developed From a Hospital-Based Administrative Database.Keisuke Ikegami, Shungo Imai, Osamu Yasumuro
|Apr 06, 2022
Development of Risk Prediction Model for Grade 2 or Higher Hypocalcemia in Patients With Bone Metastasis Treated With Denosumab Plus Cholecalciferol (Vitamin D<sub>3</sub> )/Calcium Supplement.Keisuke Ikegami, Masayuki Hashiguchi, Hayato Kizaki
|Apr 01, 2022
Characteristics of hospitals that report adverse drug reactions: Results of a nationwide survey in Japan.Masami Tsuchiya, Daisuke Kikuchi, Shiro Hatakeyama
Pageof 1
Frequent Collaborators
4 joint publications
Masami Tsuchiya
4 joint publications
Satoko Hori
3 joint publications
Taku Obara
2 joint publications
Keisuke Ikegami
2 joint publications
Hayato Kizaki
2 joint publications
Nariyasu Mano
1 joint publications
Daisuke Kikuchi
1 joint publications
Shiro Hatakeyama
1 joint publications
Yuichi Tasaka
1 joint publications
Takeshi Uchikura
